当前位置: X-MOL首页最新SCI期刊查询及投稿分析系统 › Molecular Cancer杂志
Molecular Cancer
基本信息
期刊名称 Molecular Cancer
MOL CANCER
期刊ISSN 1476-4598
期刊官方网站 http://www.molecular-cancer.com/
是否OA
出版商 BioMed Central Ltd.
出版周期 Monthly
始发年份 2002
年文章数 173
最新影响因子 37.3(2022)  scijournal影响因子  greensci影响因子
中科院SCI期刊分区
大类学科 小类学科 Top 综述
医学1区 BIOCHEMISTRY & MOLECULAR BIOLOGY 生化与分子生物学2区
ONCOLOGY 肿瘤学2区
CiteScore
CiteScore排名 CiteScore SJR SNIP
学科 排名 百分位 9.17 3.274 1.967
Biochemistry, Genetics and Molecular Biology
Molecular Medicine
4 / 165 97%
Biochemistry, Genetics and Molecular Biology
Cancer Research
6 / 191 97%
Medicine
Oncology
7 / 321 97%
补充信息
自引率 2.30%
H-index 87
SCI收录状况 Science Citation Index Expanded
官方审稿时间
Speed
59 days to first decision for reviewed manuscripts only
49 days to first decision for all manuscripts
121 days from submission to acceptance
17 days from acceptance to publication
网友分享审稿时间 数据统计中,敬请期待。
PubMed Central (PML) http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1476-4598%5BISSN%5D
投稿指南
期刊投稿网址 http://www.molecular-cancer.com/manuscript
收稿范围

Molecular Cancer is an open access, peer-reviewed journal interested in attracting high-quality original research and reviews that present or highlight significant advances in all areas of cancer and related biomedical science.

收录体裁
Research
Letters to the Editor
Reviews
投稿指南 https://molecular-cancer.biomedcentral.com/submission-guidelines
投稿模板 https://molecular-cancer.biomedcentral.com/submission-guidelines/preparing-your-manuscript
参考文献格式 https://molecular-cancer.biomedcentral.com/submission-guidelines/preparing-your-manuscript
编辑信息

Editors-in-Chief
Christophe Nicot, Kansas University Medical Center, USA 

Associate Editors

Helen Abud, Monash University, Australia 
Suresh V. Ambudkar, National Cancer Institute, USA
Suresh Alahari, Louisiana State University School of Medicine, USA 
Prof Surinder Batra, University of Nebraska Medical Center, USA 
George Calin, MD Anderson Cancer Center, USA
Amancio Carnero, Instituto de Biomedicina de Sevilla, Spain
Srikumar Chellappan, Moffitt Cancer Center and Research Institute, USA
Zhong Chen, National Institutes of Health, USA  
Liang Cheng, Indiana University Medical Center, USA 
William B. Coleman, University of North Carolina School of Medicine - Chapel Hill, USA
Federica Di Nicolantonio, Candiolo Cancer Institute, Italy
Jia Fang, Moffitt Cancer Center & Research Institute, USA
Haiyong Han, Translational Genomics Research Institute, USA 
Frank Jones, Tulane University, USA
Wei Kang, Chinese University of Hong Kong, China
Richard K Kefford, Macquarie University, Australia
Lukas Kenner, Medical University of Vienna, Austria
Sung-Hoon Kim, Kyung Hee University, South Korea
Gopal Kundu, National Center for Cell Science, India 
Sam W. Lee, Massachusetts General Hospital Cutaneous Biology Research, USA
Steven Libutti, Montefiore Medical Center, USA 
Jaroslaw Maciejewski, Cleveland Ohio Clinic, USA
Alberto M Martelli, University of Bologna, Italy
Giovanni Melillo, National Cancer Institute, USA
Ian Mills, Queen's University Belfast, UK  
Lucio Miele, Scott Cancer Center and Louisiana Cancer Research, USA
Jingxuan Pan, Sun Yat-sen University, China 
Jesus M Paramio, Molecular Oncology Unit, CIEMAT, Spain 
Yong Peng, West China Hospital, Sichuan University, China
Johannes Schmid, Medical University of Vienna, Austria 
Yongfeng Shang, Peking University Health Science Center, China 
Keshav K Singh, UAB Comprehensive Cancer Center, USA 
Shi-Yong Sun, Emory University, USA
Francois Vallette, Université de Nantes, France
Gyorgy Vereb, University of Debrecen, Hungary 
Elizabeth Vincan, University of Melbourne, Australia
Zefeng Wang, University of North Carolina - Chapel Hill, USA
Kishore Wary, University of Illinois at Chicago, USA
Haim Werner, Tel Aviv University, Israel  
Go J Yoshida, Juntendo University, Japan
Wei Zhang, The University of Texas, USA
Shengtao Zhou, West China Second Hospital, Sichuan University, China

我要分享  (欢迎您来完善期刊的资料,分享您的实际投稿经验)
研究领域:
投稿录用情况: 审稿时间:  个月返回审稿结果
本次投稿点评:
提交
down
wechat
bug